KSF MEDICAL SERVICES LIMITEDActive
Key figures
Like most small UK companies, KSF MEDICAL SERVICES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £2,000.
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 30,555 | 44,247 | 62,547 | — | — |
| Total assets | 31,994 | 45,326 | 63,266 | 40,826 | 2,035 |
| Total liabilities | 36,397 | 55,548 | 1,885 | 61 | 1,031 |
| Net assets / total equity | -4,403 | 30,874 | 61,381 | 40,315 | 403 |
| Average number of employees | 0 | 0 | 2 | 2 | 0 |
| Dividends paid | — | 2,000 | 2,000 | — | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company during the year under review was Medical Activities.
As described in the company's latest filed accounts.
Summary: KSF MEDICAL SERVICES LIMITED
Company
KSF MEDICAL SERVICES LIMITED is a private limited company registered with Companies House under company number 08364002. It was incorporated on 17 Jan 2013. Its status is active. The registered office is in Warlingham (CR6). Its nature of business (SIC 2007) is specialists medical practice activities (86220).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Jan 2025); the company files micro-entity accounts. Net assets were £403, down 99% on the previous year. Total assets were £2,035 and total liabilities £1,031. The company had an average of 0 employees. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 31 Jan 2027.